CNV
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (NCT05407636) | AbbVie | 2022-01-13 |
| Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD (NCT04704921) | AbbVie | 2020-12-29 |
| Reinterpretation of CNV With Unknown Significance: a 5-year Retrospective Analysis (NCT04575350) | Central Hospital, Nancy, France | 2019-01-01 |
| Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (NCT00726466) | Vitreous -Retina- Macula Consultants of New York | 2008-03-01 |
| Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT) (NCT00564291) | Sebastian Wolf | 2007-01-01 |
| Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration (NCT01570790) | Johns Hopkins University | 2003-05-01 |
Track CNV automatically
Every clearance here is in the API, with alerts when new ones post.